|
[Related PubMed/MEDLINE]
Total Number of Papers: 342
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: RKIP |
| Long Form |
: Raf kinase inhibitor protein |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2023 |
NeiyiKangfu tablets control the progression of endometriosis through inhibiting RAF/MEK/ERK signal pathway by targeting RKIP. |
CCK-8, EMS, ERK, MEK, NYKF, siRNA |
| 2 |
2022 |
Activation of RKIP Binding ASC Attenuates Neuronal Pyroptosis and Brain Injury via Caspase-1/GSDMD Signaling Pathway After Intracerebral Hemorrhage in Mice. |
CSF, ICH |
| 3 |
2022 |
Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer. |
LC, YY1 |
| 4 |
2022 |
Harnessing RKIP to Combat Heart Disease and Cancer. |
beta-AR, PKA |
| 5 |
2022 |
Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop. |
beta-AR, GRK2, PKA, PKC |
| 6 |
2022 |
RKIP suppresses the influenza A virus‑induced airway inflammatory response via the ERK/MAPK pathway. |
IAV |
| 7 |
2022 |
RKIP: A Pivotal Gene Product in the Pathogenesis of Cancer. |
PEBP |
| 8 |
2022 |
The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart. |
GPCR, NGS |
| 9 |
2022 |
The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment. |
--- |
| 10 |
2022 |
Understanding Mechanisms of RKIP Regulation to Improve the Development of New Diagnostic Tools. |
--- |
| 11 |
2021 |
Exploring the Binding Interaction of Raf Kinase Inhibitory Protein With the N-Terminal of C-Raf Through Molecular Docking and Molecular Dynamics Simulation. |
MD, WT |
| 12 |
2021 |
Insights of RKIP-Derived Suppression of Prostate Cancer. |
ADT, AR, CRPC, EMT, mPC, PC |
| 13 |
2021 |
Investigation of Marine-Derived Natural Products as Raf Kinase Inhibitory Protein (RKIP)-Binding Ligands. |
MNP |
| 14 |
2021 |
Limited inhibition of multiple nodes in a driver network blocks metastasis. |
--- |
| 15 |
2021 |
Liraglutide inhibits the progression of prediabetes in rats by reducing Raf-1 kinase inhibitor protein. |
ChAT, CON, FINS, H-DAR, HCNP, Ins1, LETO, LIRA, M3R, OLETF, PBO, qRT-PCR, RPMI |
| 16 |
2021 |
Mycobacterium tuberculosis RKIP (Rv2140c) dephosphorylates ERK/NF-kappaB upstream signaling molecules to subvert macrophage innate immune response. |
ERK, Mtb, NF-kappaB |
| 17 |
2021 |
Protective Effect of Raf-1 Kinase Inhibitory Protein on Diabetic Retinal Neurodegeneration through P38-MAPK Pathway. |
caspase-3, GFAP, GLAST, GS, p38 MAPK |
| 18 |
2021 |
Regulation on tumor metastasis by Raf kinase inhibitory protein: New insight with reactive oxygen species signaling. |
HSP60, MAPK, ROS, RTK |
| 19 |
2021 |
Retraction: Raf Kinase Inhibitor Protein (RKIP) Blocks Signal Transducer and Activator of Transcription 3 (STAT3) Activation in Breast and Prostate Cancer. |
STAT3 |
| 20 |
2021 |
RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in NF2-Deficient Conditions. |
MPNST, TbetaR2 |
| 21 |
2021 |
RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity. |
--- |
| 22 |
2021 |
Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-kappaB p65 pathway. |
AKI, EZH2, PRC2 |
| 23 |
2021 |
Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression. |
MTDH, PEBP1 |
| 24 |
2020 |
Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer. |
BMI1, GC, miRNA, qRT-PCR |
| 25 |
2020 |
Clinical significance of raf-1 kinase inhibitor protein in oral squamous cell carcinoma and its role in cell metastasis. |
OSCC, qRT-PCR |
| 26 |
2020 |
cMET promotes metastasis and epithelial-mesenchymal transition in colorectal carcinoma by repressing RKIP. |
c-Met, CRC |
| 27 |
2020 |
Dose-Dependent Effects of Long-Term Administration of Hydrogen Sulfide on Myocardial Ischemia-Reperfusion Injury in Male Wistar Rats: Modulation of RKIP, NF-kappaB, and Oxidative Stress. |
CSE, eNOS, iNOS, IR, NF-kappaB, nNOS, NO |
| 28 |
2020 |
GRK2 Dictates a Functional Switch of the Peripheral Mu-Opioid Receptor. |
BK, DRG, GRK2, MOR, PKC |
| 29 |
2020 |
HIF-1alpha and RKIP: a computational approach for pancreatic cancer therapy. |
HADDOCK, HIF-1alpha, PC, PPIs |
| 30 |
2020 |
LncRNA GATA6-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer via Repressing microRNA-543 to Up-Regulating RKIP. |
GATA6-AS1, lncRNAs, NSCLC |
| 31 |
2020 |
MicroRNA-18a induces epithelial-mesenchymal transition like cancer stem cell phenotype via regulating RKIP pathway in pancreatic cancer. |
EMT, miR-181a |
| 32 |
2020 |
Mycobacterium tuberculosis Raf kinase inhibitor protein (RKIP) Rv2140c is involved in cell wall arabinogalactan biosynthesis via phosphorylation. |
PEBP |
| 33 |
2020 |
PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF-kappaB signaling. |
ART, EGCG, PEBP1 |
| 34 |
2020 |
PKCdelta mediates mitochondrial ROS generation and oxidation of HSP60 to relieve RKIP inhibition on MAPK pathway for HCC progression. |
CCNE1, HCC, HSP60, MAPKs, mtROS, PKC, ROS, TPA |
| 35 |
2020 |
Resveratrol binds and activates RKIP protein in colorectal cancer. |
CRC, MAPK |
| 36 |
2020 |
RKIP Regulates Differentiation-Related Features in Melanocytic Cells. |
--- |
| 37 |
2020 |
The inhibitor effect of RKIP on inflammasome activation and inflammasome-dependent diseases. |
HFD, MSU, T2D |
| 38 |
2020 |
[Endogenous nocciceptin/orphanin FQ affect ischemic arrhythmias in rats through Raf kinase inhibitor protein]. |
beta1AR, N/OFQ, p-RKIP, SD, VEB, VF, VT |
| 39 |
2019 |
Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling. |
EGFR, NSCLC |
| 40 |
2019 |
Identifying Crosstalk between Raf Kinase Inhibitor Protein and Systemic Lupus Erythematosus. |
SLE |
| 41 |
2019 |
Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis. |
--- |
| 42 |
2019 |
Overexpression of Raf-1 kinase inhibitor protein inhibits cell invasion and migration in lung cancer cells through suppressing epithelial-mesenchymal transition. |
EMT, NSCLC |
| 43 |
2019 |
RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis. |
AML, MNs |
| 44 |
2019 |
Reduced Cholinergic Activity in the Hippocampus of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein Knockout Mice. |
HCNP, KO, PEBP1 |
| 45 |
2019 |
RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer. |
--- |
| 46 |
2019 |
RKIP negatively regulates the glucose induced angiogenesis and endothelial-mesenchymal transition in retinal endothelial cells. |
DR, HRCECs, PDR, WT |
| 47 |
2019 |
The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas. |
CIRP, Eps8, GA, MAPKs, PAs, UA |
| 48 |
2019 |
The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on beta-adrenoceptors. |
beta-AR, GRK2 |
| 49 |
2019 |
[Effect of RKIP on proliferation and migration of malignant melanoma cells and potential mechanism]. |
CCK-8, MMP, NF-kappaB, p-P65, qPCR |
| 50 |
2018 |
A New Linkage between the Tumor Suppressor RKIP and Autophagy: Targeted Therapeutics. |
EMT, MAP1LC3, LC3, NF-kappaB, STAT3 |
| 51 |
2018 |
Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors. |
GISTs, NIH |
| 52 |
2018 |
Functional Linkage of RKIP to the Epithelial to Mesenchymal Transition and Autophagy during the Development of Prostate Cancer. |
EMT, WGCNA |
| 53 |
2018 |
Inhibition of RKIP aggravates thioacetamide-induced acute liver failure in mice. |
--- |
| 54 |
2018 |
Inhibition of the Raf-1 kinase inhibitory protein (RKIP) by locostatin induces cell death and reduces the CXCR4-mediated migration of chronic lymphocytic leukemia cells. |
CLL, GRK2 |
| 55 |
2018 |
Loss of Raf kinase inhibitor protein expression is associated with human papillomavirus 16 infection in anal tumors. |
HPV, HSILs, SCC, SCCs |
| 56 |
2018 |
Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress. |
LV, NNT, Nrf2, QTL, TAC |
| 57 |
2018 |
Raf kinase inhibitor protein negatively regulates FcepsilonRI-mediated mast cell activation and allergic response. |
Gab2, IgE |
| 58 |
2018 |
Raf kinase inhibitor protein protects microglial cells against 1-methyl-4-phenylpyridinium-induced neuroinflammation in vitro. |
PD, PEBP |
| 59 |
2018 |
RKIP and peroxiredoxin 2 expression predicts the proliferative potential of gastric cancer stem cells. |
CD44 |
| 60 |
2018 |
RKIP mediates autoimmune inflammation by positively regulating IL-17R signaling. |
EAE, IL-17 |
| 61 |
2018 |
RKIP-Mediated NF-kappaB Signaling is involved in ELF-MF-mediated improvement in AD rat. |
AD, ELF-MF |
| 62 |
2018 |
RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact. |
EMT |
| 63 |
2018 |
Role of RKIP in human hepatic stellate cell proliferation, invasion, and metastasis. |
alpha-SMA, ERK, MAPK, NF-kappaB, siRNA |
| 64 |
2018 |
Targeting enhancer of zeste homolog 2 protects against acute kidney injury. |
3-DZNeP, AKI, EZH2, FA, I/R, MMP, TIMP |
| 65 |
2018 |
Targeting Raf Kinase Inhibitory Protein Regulation and Function. |
--- |
| 66 |
2018 |
The increase of miR-27a affects the role of cisplatin on proliferation and migration capacities of liver cancer cells. |
EMT, TNM |
| 67 |
2018 |
Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment. |
--- |
| 68 |
2017 |
A Model of Induction of Cerebellar Long-Term Depression Including RKIP Inactivation of Raf and MEK. |
AMPA, GRIP, LTD, MEK, PKC |
| 69 |
2017 |
Conserved salt-bridge competition triggered by phosphorylation regulates the protein interactome. |
--- |
| 70 |
2017 |
Expression of Raf kinase inhibitor protein in human hepatoma tissues by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight methods. |
HCC |
| 71 |
2017 |
Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer. |
YY1 |
| 72 |
2017 |
Mechanical stress promotes matrix synthesis of mandibular condylar cartilage via the RKIP-ERK pathway. |
MCCs |
| 73 |
2017 |
MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP. |
--- |
| 74 |
2017 |
Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma. |
MGUS, MM |
| 75 |
2017 |
Promoter methylation and expression of Raf kinase inhibitory protein in esophageal squamous cell carcinoma. |
ESCC, MSP |
| 76 |
2017 |
Raf Kinase Inhibitor Protein (RKIP) Inhibits Tumor Necrosis Factor-alpha (TNF-alpha) Induced Adhesion Molecules Expression in Vascular Smooth Muscle Bells by Suppressing (Nuclear Transcription Factor-kappaB (NF-kappaB) Pathway. |
ICAM-1, MOVACs, NF, NF-kappaB, TNF, TNF-alpha, VCAM-1 |
| 77 |
2017 |
Raf Kinase Inhibitor Protein Attenuates Ischemic-Induced Microglia Cell Apoptosis and Activation Through NF-kappaB Pathway. |
OGD |
| 78 |
2017 |
Raf Kinase Inhibitor Protein Preferentially Promotes TLR3-Triggered Signaling and Inflammation. |
MKK3 |
| 79 |
2017 |
Raf kinase inhibitor protein: lessons of a better way for beta-adrenergic receptor activation in the heart. |
beta-ARs |
| 80 |
2017 |
Reduced RKIP expression levels are associated with frequent non-small cell lung cancer metastasis and STAT3 phosphorylation and activation. |
JAK/STAT, NSCLC |
| 81 |
2017 |
RKIP is decreased in laboring myometrium and modulates inflammation-induced pro-labor mediators. |
ERK, NF-kappaB, siRKIP |
| 82 |
2017 |
RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer. |
CSC, GLI1, NSCLC, Smo |
| 83 |
2017 |
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein. |
DC, PEBP1 |
| 84 |
2017 |
TWIN SISTER OF FT (TSF) Interacts with FRUCTOKINASE6 and Inhibits Its Kinase Activity in Arabidopsis. |
FRK6, FT, SD, TSF |
| 85 |
2017 |
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma. |
ccRCC, CKD, HS, PCa |
| 86 |
2017 |
Various UVB doses affect change of raf kinase inhibitor protein, nitric oxide and proliferation in keratinocytes. |
NO |
| 87 |
2016 |
A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-kappaB-Snail circuit. |
CRC, lncRNAs, ROC curve |
| 88 |
2016 |
A Raf kinase inhibitor demonstrates antiviral activities both invitro and invivo against different genotypes of virulent Newcastle disease virus. |
ND, NDV, RKIV |
| 89 |
2016 |
Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein. |
--- |
| 90 |
2016 |
Didymin ameliorates hepatic injury through inhibition of MAPK and NF-kappaB pathways by up-regulating RKIP expression. |
--- |
| 91 |
2016 |
Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells. |
OVD |
| 92 |
2016 |
Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study. |
--- |
| 93 |
2016 |
Enrichment of Metabolite-Binding Proteins by Affinity Elution in Tandem Hydrophobic Interaction Chromatography (AETHIC) Reveals RKIP Regulating ERK Signaling in an ATP-Dependent Manner. |
AETHIC |
| 94 |
2016 |
Epigenetic changes and nuclear factor-kappaB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast cancer SUM 159 cells. |
5-Aza, DHMEQ, NF-kappaB, PCR, TNBCs, TSA |
| 95 |
2016 |
GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity. |
GRK2, MOR, PKC |
| 96 |
2016 |
Increased chemoresistance via Snail-Raf kinase inhibitor protein signaling in colorectal cancer in response to a nicotine derivative. |
CRC, CSC, EMT |
| 97 |
2016 |
Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP. |
AML |
| 98 |
2016 |
Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells. |
ECM, MAPK |
| 99 |
2016 |
Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis. |
--- |
| 100 |
2016 |
Molecular mechanism of hepatitis B virus (HBV) on suppression of raf kinase inhibitor protein (RKIP) expression. |
HBV, HBx |
|
A Search Service for Abbreviation / Long Form
